Still feeling hungry on Wegovy — why it happens and what to do

Does Wegovy suppress hunger straight away, or does it take time?

For most people, appetite does not vanish overnight. Wegovy's titration schedule (starting at 0.25 mg and stepping up through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose) exists partly to let your body adjust gradually and reduce side effects. At lower doses, the appetite-suppressing effect is generally milder. That is by design, not a sign the medicine is failing.

Clinical trial data help put this in context. In the STEP 1 trial, published in the New England Journal of Medicine, participants on semaglutide 2.4 mg lost an average of around 15% of body weight over 68 weeks, but that reduction built progressively across months, not weeks. Hunger tended to ease as doses increased. If you are still hungry on Wegovy at the 0.5 mg stage, it is worth knowing that the medicine you are taking now is not the maintenance dose your results will be measured against.

Some people also experience what is sometimes called the "end-of-week" effect: hunger creeping back in the 24 to 48 hours before the next injection as semaglutide levels in the body begin to taper. This is a pharmacological pattern, not a relapse. Keeping a simple record of when hunger tends to peak can be a useful thing to share with your prescriber.

Why does food choice still matter when you're on a GLP-1 medicine?

One thing our prescribers hear regularly: patients who expected Wegovy to make food irrelevant find that certain meals still leave them hungry an hour later. That makes biological sense. Wegovy slows gastric emptying and signals fullness through gut and brain pathways, but it does not override the way different macronutrients behave in the body.

Protein is the most satiating macronutrient, calorie for calorie. Fibre slows glucose absorption and prolongs the feeling of fullness. Ultra-processed foods and high-sugar snacks, by contrast, digest quickly and can trigger renewed appetite even when overall calorie intake is low. On Wegovy, these differences become more noticeable, not less, because the medicine has already suppressed part of your hunger signal, and what remains is more directly tied to what you just ate.

The NHS guidance on semaglutide recommends taking Wegovy alongside a reduced-calorie diet and increased physical activity, which is part of the licensed indication, not optional advice. For practical guidance on what tends to work well on a GLP-1 medicine, the page on what to eat on Wegovy covers the evidence-backed principles in more detail. A registered dietitian can tailor that to your specific situation.

Could hunger mean the dose is not right for you?

If you are on the 2.4 mg maintenance dose and still feel meaningfully hungry most of the time, that is worth a conversation with your prescriber rather than an assumption that the medicine simply does not work for you. There are a few things that matter here.

First, how long have you been on the current dose? Appetite suppression can continue to improve for several weeks after a dose increase as your system adjusts. Raising the question after two weeks at 2.4 mg is different from raising it after three months. Second, since January 2026 the MHRA has approved a higher 7.2 mg maintenance dose for Wegovy, initially supplied as three 2.4 mg pens per week and now also available as a dedicated single-dose pen, something that may be clinically appropriate for some people. Whether that option suits your circumstances is a clinical decision; the page on why you might still feel hungry on Wegovy explores the dose dimension in more detail.

Third, there are individual differences in how people respond to semaglutide. Tirzepatide, the active ingredient in Mounjaro, activates both GLP-1 and GIP receptors. In the SURMOUNT-1 trial, that dual mechanism produced greater average appetite suppression and weight loss than the figures seen with semaglutide 2.4 mg. Some people who are still feeling hungry on semaglutide find a different medicine better suited to them, again, a prescriber decides that, not a search engine. If you are considering your options, exploring what is available through a clinically reviewed weight-loss consultation is the straightforward next step.

When should persistent hunger prompt you to contact your prescriber?

Hunger alone is rarely urgent. But there are circumstances where it is better to get in touch sooner rather than later. If your hunger has noticeably worsened after a period of it having settled, that can occasionally be linked to nausea or vomiting that has reduced your actual food intake, causing reactive hunger rather than the medicine losing effect. Dehydration from GI side effects can also mimic hunger.

If you are eating very little and still feeling unsatisfied (or if you are finding yourself preoccupied with food in a way that feels distressing) that is worth flagging. The full picture of how hunger changes on Wegovy includes experiences that vary significantly, and a prescriber can look at your pattern in context. At nume, every query about treatment goes to a real clinician; there is no chatbot between you and someone who can actually help. You can also reach the team directly through the contact page.

For most people, still feeling hungry on Wegovy is not a reason to stop. It is a prompt to look more closely at dose timing, food choices, and where you are in the titration process. Getting those factors right is part of the clinical support a good prescriber provides.